NR 546 Advanced Pharmacology Psychopharmacology for the Psychiatric-Mental Health Nurse Practitioner MIDTERM EXAM- Chamberlain

NR 546 Advanced Pharmacology Psychopharmacology
for the Psychiatric-Mental Health Nurse Practitioner
MIDTERM EXAM- Chamberlain




1. A patient
k, k, recovering from
k, a
k, k, stroke has
k, trouble
k, with
k, speech
k,




comprehension and works with a speech therapist twice a week. Which
k, k, k, k, k, k, k, k, k, k, k,




k, part of the patient's brain has been affected by the stroke?
k, k, k, k, k, k, k, k, k, k,




A. The Broca's area
k, k,




B. The Basal ganglia
k, k,




C. The Limbic system
k, k,




D. The Wernicke's area
k, k,




ANS>> D. The Wernicke's area
k, k, k, k,




2. Which of the following poses a potential ethical concern when
k, k, k, k, k, k, k, k, k,




prescribing psychiatric medications?
k, k, k,




A. The patient is homeless and uninsured
k, k, k, k, k,




B. The patient poses a risk to themself as they state they are experiencing very
k, k, k, k, k, k, k, k, k, k, k, k, k,




k, scary auditory and visual hallucinations
k, k, k, k,


,C. The patient's family voices a stigma against psychiatric medications
k, k, k, k, k, k, k, k,




D. The patient states they worry about the potential side effects of the
k, k, k, k, k, k, k, k, k, k, k,




k, med- ication k,




ANS>> B. The patient poses a risk to themself as they state they are experiencing
k, k, k, k, k, k, k, k, k, k, k, k, k, k,




k, very scary auditory and visual hallucinations
k, k, k, k, k,




3. What is the name of the lobe that controls visual processing?
k, k, k, k, k, k, k, k, k, k,




A. Gyrus
B. Frontal Lobe k,




C. Occipital Lobe k,




D. Parietal Lobe k,




ANS>> C. Occipital Lobe k, k, k,




4. The cerebellum, cerebrum, brain stem, and butterfly-shaped portion of
k, k, k, k, k, k, k, k,




k, the central spinal cord are comprised of
k, k, k, k, k, k, which contains neural
k, k,




k, cell bodies, axon terminals, dendrites, and all nerve synapses.
k, k, k, k, k, k, k, k,




A. Frontal lobe k,




B. White mater k,




C. Grey mater k,




D. Corpus callosum k,




ANS>> C. Grey mater k, k, k,






,5. What is the function of the central sulcus?
k, k, k, k, k, k, k,




A. Separates the temporal from the occipital lobe k, k, k, k, k, k,




B. Separates the frontal from the parietal lobe k, k, k, k, k, k,




C. Involved in complex motor activities k, k, k, k,




D. Keeps us alert to our environment
k, k, k, k, k,




ANS>> B. Separates the frontal from the parietal lobe
k, k, k, k, k, k, k, k,




6. A 22-year-old patient recently diagnosed with bipolar disorder and
k, k, k, k, k, k, k, k,




k, states "I'm not crazy" and is refusing to take his prescribed medication.
k, k, k, k, k, k, k, k, k, k, k,




Which type of factor is contributing to this patient's nonadherence?
k, k, k, k, k, k, k, k, k, k,




A. Client factors k,




B. Clinician factors k,




C. Structural factors k,




D. Environmental factors k,




ANS>> C. Structural factors k, k, k,




7. Using Dell'Osso et al.'s sequential framework of priorities to promote med-
k, k, k, k, k, k, k, k, k, k,




k, ication adherence, determine which step is being defined: The PMHNP ex-
k, k, k, k, k, k, k, k, k, k,




k, plains the mechanism of action, anticipated time to experience effects,
k, k, k, k, k, k, k, k, k,




k, side effects, and lifestyle instructions to a patient after prescribing
k, k, k, k, k, k, k, k, k,




Wellbutrin.
k,




A. Diagnosis
B. Medication education k,



, C. Monitoring plan
k,